You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Portable System with Li Foil MWPC Neutron Detectors

    SBC: RADIATION DETECTION TECHNOLOGIES, INC.            Topic: DTRA14B005

    At the completion of the research and development effort a Li foil multi-wire proportional counter (MWPC) neutron detector with more than 625 cm^2 of active area will be included in a portable radiation detection system. The system is expected to have an intrinsic thermal neutron detection efficiency of 55% or greater and gamma-ray rejection ratio (GRR) of 1.0x10^-8 or better. A gamma-ray spectrom ...

    STTR Phase I 2015 Department of DefenseDefense Threat Reduction Agency
  2. Rapid Monitoring and Assessment of Tubercuolosis Treatment at the Point of Care Using Breath

    SBC: NanoSynth Materials and Sensors Inc.            Topic: NHLBI

    DESCRIPTION provided by applicant Problem and Significance According to the CDC global statistics nearly of the world is infected with Tuberculosis TB In million f peopled infected lived in what is considered a high burden country Countries such as India Peru China sub Saharan Africa and others have significant regions endemic for TB particularly among the lower income ...

    STTR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health
  3. Intraperitoneal Nanoparticulate Paclitaxel

    SBC: CRITITECH            Topic: N/A

    DESCRIPTION (provided by applicant): Paclitaxel has shown promise in the treatment of several types of cancers, including ovarian cancer. The long-term goals of this research are to design a formulation of paclitaxel that is effective in the treatment of cancer and exhibits no formulation related toxicity. The present set of studies utilizes the techniques of precipitation with compressed antisol ...

    STTR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health
  4. Homogeneous Mutation Scanning

    SBC: IDAHO TECHNOLOGY            Topic: N/A

    DESCRIPTION (provided by applicant): Our objective is to provide a homogeneous, closed-tube system for DNA mutation scanning on a high-throughput platform. For many complex genetic diseases, it is very difficult and expensive to screen for all possible mutations that may cause the disease. We propose a relatively simple solution. Certain dyes are compatible with PCR and can detect sequence alterat ...

    STTR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health
  5. Nanostenting Hydrogels for Sinus Surgery

    SBC: RECOGNITION ROBOTICS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Chronic sinus disease affects over 31 million Americans, and surgery for this disease is performed over 200,000 times annually. Success in functional endoscopic sinus surgery (FESS) is frequently limited by poor wound healing and scar contracture. Sentrx Surgical, Inc., a University of Utah startup formed to commercialize in situ crosslinkable glycosaminogly ...

    STTR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health
  6. Thiol-Reactive Crosslinkers for Biomaterials

    SBC: RECOGNITION ROBOTICS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): A limited number of cytocompatible crosslinkers are available for the preparation of cell-seeded hydrogels and in vivo biocompatible injectable biomaterials. To expand this selection, Sentrx Surgical, Inc. will synthesize and evaluate a series of thiol-reactive bivalent and polyvalent crosslinkers based on polyethylene glycol (PEG). We will determine the relati ...

    STTR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health
  7. Crosslinkable Hydrogels for Tympanic Membrane Repair

    SBC: RECOGNITION ROBOTICS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Tympanic membrane perforation (TMP, or "ruptured eardrum") is a common occurrence caused by trauma, ear infections, or pressure equalization tube insertion. TMP may cause significant hearing loss or a portal for water exposure or infection. Current treatment uses a patient's own adipose or soft tissue to provide a template for repair of the perforation, often r ...

    STTR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government